Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Nara

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Journal of Virological Methods|May 1, 1996
A cytopathic infectivity assay of human immunodeficiency virus type 1 in human primary macrophagesS C Wu, J L Spouge, M J Merges, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 1, 1982
Effects of chloramphenicol on the development of immune responses to canine distemper virus in beagle pupsP L Nara, L E Davis, L H Lauerman, et al.
Virology|December 15, 1996
Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cellsW P Tsai, S R Conley, H F Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120P L Nara, W G Robey, M A Gonda, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycleP L Nara, K M Hwang, D M Rausch, et al.
Journal of Virology|February 1, 1993
Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individualsK Hariharan, P L Nara, V M Caralli, et al.
AIDS Research and Human Retroviruses|March 1, 1996
Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunizationJ D Ahlers, N Dunlop, C D Pendleton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1993
Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizationsJ D Ahlers, C D Pendleton, N Dunlop, et al.
The Journal of Clinical Investigation|June 1, 1994
Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workersS H Pincus, K G Messer, P L Nara, et al.
Journal of Virology|October 1, 1995
Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophagesS C Wu, J L Spouge, S R Conley, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Journal of Virological Methods|May 1, 1996
A cytopathic infectivity assay of human immunodeficiency virus type 1 in human primary macrophagesS C Wu, J L Spouge, M J Merges, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 1, 1982
Effects of chloramphenicol on the development of immune responses to canine distemper virus in beagle pupsP L Nara, L E Davis, L H Lauerman, et al.
Virology|December 15, 1996
Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cellsW P Tsai, S R Conley, H F Kung, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120P L Nara, W G Robey, M A Gonda, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycleP L Nara, K M Hwang, D M Rausch, et al.
Journal of Virology|February 1, 1993
Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individualsK Hariharan, P L Nara, V M Caralli, et al.
AIDS Research and Human Retroviruses|March 1, 1996
Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunizationJ D Ahlers, N Dunlop, C D Pendleton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1993
Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizationsJ D Ahlers, C D Pendleton, N Dunlop, et al.
The Journal of Clinical Investigation|June 1, 1994
Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workersS H Pincus, K G Messer, P L Nara, et al.
Journal of Virology|October 1, 1995
Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophagesS C Wu, J L Spouge, S R Conley, et al.
Pageof 8